Page 1905 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

1332 Index

Brain tissue oxygen monitoring, C Cardiac arrhythmias, 258, 278–293
1131–1132, 1132f Calcineurin inhibitors, use of, in critically ill antiarrhythmic drug therapy,
Brazilian hemorrhagic fever, 739–740 patient, 1252 279–280, 280ft
Breathing, 251 Calcium, 957–962 cardioversion/defibrillation, 290
in burn patients, 1181–1182 hypercalcemia and, 960–962, 961t, 962t supraventricular tachyarrhythmias,
British Association of Critical Care Nurses on hypocalcemia and, 957–960, 958t, 286–287, 287f
patient-nurse ratio, 19 959t, 960t implantable cardioverter defibrillators,
Bronchial artery embolization (BAE), metabolism and, 957, 957f, 958f 290–291f, 292f, 293
214–216, 215f, 511 Calcium channel blockers, 297, 302, tachyarrhythmias, 278–279, 279ft
Bronchial necrosis and dehiscence, 1211–1212 ventricular tachyarrhythmias, 280–286,
1095–1096 Calcium chloride, 959–960 281f, 282t, 283t, 284ft, 285f, 286f
Bronchiolitis obliterans organizing Calcium gluconate, 959–960 Cardiac asthma, 498
pneumonia, 888 Calcium sensitizers, 316 Cardiac biomarkers, 294, 295–296
Bronchiolitis obliterans syndrome, 887–888 Calibration, 85 Cardiac catheterization, 342
Bronchoalveolar lavage, 457, 512 Campylobacter, 676 in diagnosing aortic regurgitation, 348
Bronchoscopy Candida in diagnosing mitral regurgitation, 351
quantitative cultures of distal specimens as cause of esophagitis, 705 Cardiac computed tomography, in diagnosing
obtained by, 526–528, 527f invasive infections and, 643–644, 644t, 645 valvular diseases, 345
quantitative cultures of distal specimens urinary tract infection due to, 701–702 Cardiac disorders, abnormal waveforms in,
obtained without, 528 Candidemia, 618, 644–645 195–200, 195f, 196f, 197f, 198f, 199f
Bronchovenous air embolism, 1158 treatment of, 648–649 Cardiac dysfunction, 256
Budd-Chiari syndrome, 221, 223, 868 Candidiasis, 1284 assessment of, 266–268, 266f, 267t
Bulbar impairment, 822 identifying patients at risk for, 647 in pregnancy, 1259–1260
Bullous pemphigoid, 1292, 1292f intra-abdominal, 649 Cardiac evaluation, in organ transplantation,
Bundibugyo ebolavirus, 740 risks factors for invasive, 644 1111–1112, 1112t
Bunyaviridae, 673, 740–743 strategies to prevent invasive, Cardiac herniation, 1073
Burn patients 647–648, 647t Cardiac magnetic resonance imaging, in
American Burn Association establishment Candiduria, catheter-associated, 702–703 diagnosing right heart syndromes,
of criteria for, 1188–1189 Cannulation, 473–474, 473f, 474f 311–312, 312t
critical care for, 1180–1189 Carbapenems, 545–546, 549t Cardiac massage, 1158
additional therapies, 1189 for febrile neutropenic patients, 612 Cardiac mechanical devices, temporary,
airway management in, 1181, 1181f Carbon dioxide enhancement, in 1072–1073
breathing in, 1181–1182 interventional radiology, 209 Cardiac morbidity, assessment of, for
circulation in, 1182, 1183f, 1184f Carbon monoxide, 1212 noncardiac surgery, 1055, 1055t
first-line monitoring in, 1186 Carboplatin, 899 Cardiac output, 242, 245–248, 246f, 247f
fluid creep, 1186 Carcinoid syndrome, 1077 effects of pressure outside the heart on, 235,
laboratory studies, 1186 Carcinoid tumors, 1077 235f, 236t
pulmonary artery/central venous Carcinoma, hepatocellular, 1101 fluid responsiveness and, 569
catheters, 1186 Cardiac, electric trauma and, 1177 systemic vessels in controlling, 233–238,
resuscitation end points, 1186 Cardiac arrest 233f, 234f, 235f, 236t
vitamin C resuscitation, 1186 aspects of defibrillation, 171–172 Cardiac pacing, in intensive-care unit, 290
infection/inflammation/sepsis in, 1187 asystole, 170–171 Cardiac pump function, 268
metabolism/nutrition in, 1187–1188 automatic external defibrillators, 173 Cardiac surgery, corticosteroids in
anabolic steroids, 1188 basic life support, 168 treating, 985
ß-Blockade, 1188 bradycardia, 170 Cardiac tamponade, 237, 338–340, 880,
endocrine and glucose monitoring, defined, 166 880f, 1069–1070, 1155–1156,
1188 ending resuscitation efforts, 171 1157–1158
enteral, 1187–1188 ethical issues, 173–174 diagnosis of, 338–339, 338f
pain management in, 1188 etiologies of, 167t invasive hemodynamics, 339, 339f
physiotherapy in, 1188 hypothermia in, 176–177, 176f, 177t pathophysiology, 338
preventable complications in, induced, 173 pericardiocentesis, 339–340, 339f
1186–1187 initial assessment, 168 Cardiac ultrasonography, 206–208
adrenal insufficiency, 1187 limitations on efforts, 173 Cardiogenic shock, 229f, 236–237, 256–257t,
compartment syndromes, 1187 pediatric, 167 258–259, 306–307, 306f
deep venous thrombosis, 1187 pharmacologic therapy of, 173, 173t Cardiopulmonary bypass, 1068, 1093
heparin-induced prevention of, 167–168 Cardiopulmonary monitoring in sepsis, 569
thrombocytopenia, 1187 pulseless electrical activity, 170, 170t Cardiopulmonary resuscitation (CPR),
hypothermia, 1186 resuscitation team organization, 168 166–174
neutropenia, 1187 three-phase time-sensitive model of, in pregnancy, 1263–1264, 1263t
stress ulcers, 1187 172–173, 172f Cardiorespiratory system, goal of, 242
resuscitation goals in, 1182, 1185f three-phase time-sensitive model of Cardiotoxicity, 896–897, 896t
shock pathophysiology in, 1183, therapy, 172–173, 172f Cardiovascular dysfunction, in sepsis, 565
1185–1186 ventricular fibrillation/ventricular Cardiovascular effects, obesity and,
transfer criteria in, 1188–1189 tachycardia without a pulse, 1306–1307
wound management in, 1188 169–170 Cardiovascular system, primary role of, 228
Burst fractures, 1147 ventricular tachycardia with a pulse, 169 Cardioversion/defibrillation, 290

Index.indd 1332 23-01-2015 15:33:51